A monoclonal antibody-based characterization of autoantibodies against glutamic acid decarboxylase in adults with latent autoimmune diabetes

Autoimmunity

Volumn 28, Issue 2, 1998, Pages 61-68

  Ziegler, B ^a   Strebelow, M ^a   Rjasanowski, I ^b   Schlosser, M ^a   Ziegler, M ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b Clinicum Karlsburg   (Germany)

Author keywords

Autoantibodies; Competitive radiobinding assay; Epitope specificity; Latent type I diabetes; Murine monoclonal glutamate decarboxylase antibodies

Indexed keywords

AUTOANTIBODY; EPITOPE; GLUTAMATE DECARBOXYLASE; MONOCLONAL ANTIBODY;

ADULT; AMINO TERMINAL SEQUENCE; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; DIABETES MELLITUS; FEMALE; HUMAN; MALE;

EID: 0031768145     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939809003868     Document Type: Article

References (26)

1. Castano, L. and Eisenbarth, G.S. Type I diabetes: a chronic autoimmune disease of human, mouse and rat. Annu. Rev. Immunol. 1990, 8: 647-678.
2. Baekkeskov, S., Aanstoot, H.J., Christgau, S., Reetz, S., Solimena. A., Cascalho, M. et al. Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990, 347: 151-156.
3. Solimena, M. and De Camilli, P. Autoimmunity to glutamic acid decarboxylase (GAD) in stiff-man syndrome and insulin-dependent diabetes mellitus. Trenda Neurosci. 1991, 14: 452-457.
4. Björk, E., Velloso, L.A., Kämpe, I. and Karlsson, F.A. GAD autoantibodies in IDDM. stiff-man syndrome and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes 1994, 43: 161-165.
5. Solimena, M., Butler, M.H. and De Camilli, P. GAD. diabetes and Stiff-Man syndrome: Some progress and more questions. J. Endocrinol. Invest. 1994, 17: 509-520.
6. Kim, J., Namchuk, M., Bugawan, T., Fu, Q., Jaffe, M., Shi, Y. et al. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65. distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J. Exp. Med. 1994, 180: 595-606.
7. Richter, W., Shi, Y and Baekkeskov, S. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc. Natl. Acad. Sci. USA 1993, 90: 2832-2836.
8. Zimmet, P.Z., Tuomi, T., Mackay, I.R., Rowley, M.J., Knowles, W., Cohen, M. et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diab. Med. 1994, 11: 299-303.
9. Ziegler, B., Schlosser, M., Lühder, F., Strebelow, M., Augstein, P., Northemann, W. et al. Murine monoclonal glutamic acid decarboxylase (GAD) 65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and Stiff-man syndrome. Acta Diabetol. 1996, 33: 225-231.
10. Ziegler, B., Lucke, S., Köhler, E., Hehmke, B., Schlosser, M. and Witt, S. Monoclonal antibody-mediated cytotoxicity against rat beta-cells detected in vitro does not cause beta-cell destruction in vivo. Diabetologia 1992, 35: 608-613.
11. Ziegler, B., Augstein, P., Lühder, F., Northemann, W., Hamann, J., Schlosser, M. et al. Monoclonal antibodies specific to the glutamic acid decarboxylase 65 kDa isoform derived From a non-obese diabetic (NOD) mouse. Diab. Res. 1994, 25: 47-64.
12. Hamann, J., Lühder, F., Schlosser, M., Vieregge, P., Ziegler, B. and Ziegler, M. Specific screening of monoclonal antibodies to glutamic acid decarboxylase by a sandwich assay using the natural target antigen plate-bound via autoantibodies. Diab. Res. 1993, 24: 57-66.
13. Hamann, J., Hahimann, J., Strebelow, M., Ziegler, B and Ziegler, M. A monoclonal antibody based enzyme-linked immunosorbent assay for the determination of GAD65, the smaller isoform of glutamic acid decarboxylase. Diab. Res. 1994, 26: 109-116
14. Schlosser, M., Witt, S., Ziegler, B. and Ziegler, M. Influence of target cell preparation on binding of monoclonal islet cell reactive antibodies (mc-ICRA) in cellular enzyme-linked immunosorbent assay (CELISA). J. Immunol. Meth. 1991, 140: 101-109.
15. Wu, J.Y., Matusuda, T. and Roberts, E. Purification and characterization of glutamate decarboxylase from mouse brain. J. Biochem. 1973, 248: 3029-3034.
16. Lühder, F., Woltanski, K.P., Hamann, J., Klöting, I., Ziegler, B. and Ziegler, M. Detection of antibodies against both isoforms of glutamate decarboxylase in BB/OK rats by Western blotting and immuno-trapping enzyme activity assay. Diab. Res. 1992, 20: 97-107.
17. Laemmli, U.K. Most commonly used discontinuous butler system for SDS electrophoresis. Nature 1970, 227: 680-685.
18. Daw, K. and Powers, A.C. Two distinet glutamic acid decarboxylase autoantibody specificities in IDDM target different epitopes. Diabetes 1995, 44: 216-220.
19. Vieregge, P., Branczyk, B., Barnett, W., Stöcker, W., Soyka, D. and Kömpf, D. Stiff-man Syndrome. Report of 4 cases. Nervenarzt 1994, 65: 712-717
20. Lühder, F., Schlosser, M., Mauch, L., Haubruck, H., Rjasanowski, I., Michaelis, D. et al. Autoantibodies against GAD65 rather than GAD67 precede the onset of type 1 diabetes. Autoimmunity 1994, 19: 71-80.
21. DeAizpurua, H.J., Harrison, L.C. and Cram, D.S. An ELISA for antibodies to recombinant glutamic acid decarboxylase in IDDM. Diabetes 1992, 41: 1182-1187.
22. Hagopian, W.A., Michelsen, B., Karlsen, A.E., Moddy, A., Grubin, C.E., Rowe, R. et al. Autoantibodies in IDDM primarily recognize the 65,000-Mr rather than the 67,000-Mr isoform of glutamic acid decarboxylase. Diabetes 1993, 42: 631-636.
23. Seissler, J., Amann, J., Mauch, L., Haubruck, H., Wolfahrt, S., Bieg, S. et al. Prevalence of autoantibodies to the 65- and 67-KD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J. Clin. Invest. 1993, 92: 1394-1399.
24. Butler, M.H., Solimena, M., Dirkx, R., Hayday, A. and De Camilli, P. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in Stiff-man syndrome. J. Exp. Med. 1993, 178: 2097-2106.
25. Fallorni, A., Ackefors, M., Carlberg, C., Daniels, T., Persson, B., Robertson, J. et al. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM. Diabetologia 1996, 39: 1091-1098.
26. Li, L., Hagopian, W.A., Brashear, H.R., Daniels, T. and Lernmark, A. Identification of autoantibody epitopes of glutamic acid decarboxylase in Stiff-man syndrome patients. J. Immunol. 1994, 152: 930-934.